TABERNIL ANTIASMATICO
  • Diphenhydraminhydrochlorid
  • Ephedrinhydrochlorid
  • 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione
  • Deksametazona nātrija fosfāts
  • Valid
Authorised in these countries:
  • Spain
Export to PDF

Product identification

Medicine name:
TABERNIL ANTIASMATICO
Active substance and strength:
  • Diphenhydraminhydrochlorid
  • Ephedrinhydrochlorid
  • 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione
  • Deksametazona nātrija fosfāts
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR03CK
Authorisation number:
  • 2066 ESP
Product identification number:
  • d20b9dff-0561-4524-8e7a-1938e287dc3b
Permanent identification number:
  • 600000082773

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Ornamental bird

Availability

Package description:
Manufacturing sites for batch release:
This information is not available for this product.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • 2066 ESP
Date of authorisation status change:
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
  • Spain
Responsible authority:
  • (AEMPS)
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
Package Leaflet (PDF)
First published:
Last updated:
Labelling (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."